D.E. Shaw & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-118,100
Closed -$3.69M 5117
2025
Q4
$3.69M Sell
118,100
-49,200
-29% -$1.21M ﹤0.01% 2566
2025
Q3
$3.38M Buy
167,300
+19,800
+13% +$348K ﹤0.01% 2548
2025
Q2
$2.47M Buy
147,500
+49,200
+50% +$794K ﹤0.01% 2585
2025
Q1
$1.51M Sell
98,300
-41,200
-30% -$736K ﹤0.01% 2814
2024
Q4
$3.07M Hold
139,500
﹤0.01% 2377
2024
Q3
$2.51M Sell
139,500
-16,300
-10% -$285K ﹤0.01% 2526
2024
Q2
$2.53M Buy
155,800
+39,200
+34% +$604K ﹤0.01% 2440
2024
Q1
$1.65M Sell
116,600
-235,000
-67% -$2.96M ﹤0.01% 2774
2023
Q4
$3.67M Sell
351,600
-120,000
-25% -$1.12M 0.01% 2167
2023
Q3
$4.81M Buy
471,600
+75,000
+19% +$698K 0.01% 1841
2023
Q2
$2.99M Buy
396,600
+151,600
+62% +$1.23M ﹤0.01% 2300
2023
Q1
$2.17M Sell
245,000
-955,000
-80% -$9.44M ﹤0.01% 2633
2022
Q4
$10.9M Buy
1,200,000
+300,000
+33% +$2.62M 0.02% 1356
2022
Q3
$7.26M Hold
900,000
0.01% 1678
2022
Q2
$6.77M Sell
900,000
-130,500
-13% -$1.14M 0.01% 1781
2022
Q1
$9.68M Sell
1,030,500
-134,600
-12% -$1.12M 0.01% 1614
2021
Q4
$9.33M Buy
1,165,100
+270,500
+30% +$2.44M 0.01% 1719
2021
Q3
$8.71M Buy
894,600
+744,600
+496% +$6.97M 0.01% 1624
2021
Q2
$1.49M Sell
150,000
-50,000
-25% -$529K ﹤0.01% 3220
2021
Q1
$2.31M Sell
200,000
-1,014,800
-84% -$11.6M ﹤0.01% 2467
2020
Q4
$11.7M Sell
1,214,800
-236,900
-16% -$2.27M 0.01% 1293
2020
Q3
$13.1M Buy
1,451,700
+156,900
+12% +$1.66M 0.02% 1061
2020
Q2
$16M Sell
1,294,800
-117,000
-8% -$1.32M 0.02% 899
2020
Q1
$12.7M Sell
1,411,800
-1,416,100
-50% -$14.5M 0.02% 869
2019
Q4
$27.7M Sell
2,827,900
-1,129,500
-29% -$10.1M 0.04% 655
2019
Q3
$27.2M Buy
3,957,400
+940,000
+31% +$7.2M 0.04% 629
2019
Q2
$27.9M Buy
3,017,400
+2,016,700
+202% +$24.3M 0.04% 595
2019
Q1
$15.7M Sell
1,000,700
-2,576,300
-72% -$45.4M 0.03% 850
2018
Q4
$55.2M Sell
3,577,000
-620,000
-15% -$12.7M 0.1% 316
2018
Q3
$90.4M Sell
4,197,000
-100,000
-2% -$2.32M 0.14% 226
2018
Q2
$105M Sell
4,297,000
-855,700
-17% -$17.5M 0.17% 172
2018
Q1
$88.1M Buy
5,152,700
+235,000
+5% +$4.59M 0.15% 215
2017
Q4
$93.2M Buy
4,917,700
+1,906,700
+63% +$28.7M 0.17% 189
2017
Q3
$53M Buy
3,011,000
+1,183,500
+65% +$26.6M 0.1% 309
2017
Q2
$60.7M Buy
1,827,500
+419,100
+30% +$13M 0.12% 247
2017
Q1
$45.2M Buy
1,408,400
+674,900
+92% +$23M 0.1% 304
2016
Q4
$26.6M Buy
733,500
+260,000
+55% +$10.4M 0.06% 510
2016
Q3
$21.8M Buy
473,500
+223,500
+89% +$11.7M 0.05% 540
2016
Q2
$12.6M Buy
250,000
+160,000
+178% +$8.52M 0.03% 768
2016
Q1
$4.82M Sell
90,000
-88,200
-49% -$5.18M 0.01% 1309
2015
Q4
$11.7M Hold
178,200
0.02% 903
2015
Q3
$10.1M Sell
178,200
-91,800
-34% -$5.95M 0.02% 967
2015
Q2
$16M Buy
270,000
+140,000
+108% +$8.64M 0.03% 726
2015
Q1
$8.1M Sell
130,000
-775,800
-86% -$45.1M 0.02% 1088
2014
Q4
$52.1M Sell
905,800
-235,000
-21% -$13.1M 0.1% 344
2014
Q3
$61.3M Buy
1,140,800
+140,700
+14% +$7.45M 0.12% 286
2014
Q2
$52.4M Buy
1,000,100
+385,100
+63% +$19.7M 0.11% 319
2014
Q1
$32.5M Buy
615,000
+585,900
+2,013% +$27.1M 0.07% 430
2013
Q4
$1.17M Hold
29,100
﹤0.01% 3030
2013
Q3
$1.1M Hold
29,100
﹤0.01% 2951
2013
Q2
$1.14M Buy
+29,100
New +$1.13M ﹤0.01% 2604

Other funds holding TEVA